Cargando…
Vitamin E and Alzheimer’s disease: what do we know so far?
Vitamin E has been proposed as a potential clinical intervention for Alzheimer’s disease (AD) given the plausibility of its various biological functions in influencing the neurodegenerative processes associated with the condition. The tocopherol and tocotrienol isoforms of vitamin E have multiple pr...
Autores principales: | Browne, Declan, McGuinness, Bernadette, Woodside, Jayne V, McKay, Gareth J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645610/ https://www.ncbi.nlm.nih.gov/pubmed/31409980 http://dx.doi.org/10.2147/CIA.S186760 |
Ejemplares similares
-
Serum concentrations of vitamin E and carotenoids are altered in Alzheimer's disease: A case-control study
por: Mullan, Kathryn, et al.
Publicado: (2017) -
Vitamin D and Temporomandibular Disorders: What Do We Know So Far?
por: Kui, Andreea, et al.
Publicado: (2021) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
Serum xanthophyll carotenoids are associated with estimated glomerular filtration rate in an aged cohort
por: Browne, Declan, et al.
Publicado: (2019) -
Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021)